Clinical trial
A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients With Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
NCT03168776 is registered in ClinicalTrials.gov with Sino Medical Sciences Technology Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients With Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
- Lead sponsor
- Sino Medical Sciences Technology Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 13, 2017
- Completion date
- October 1, 2024
- Enrollment
- 1,629 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.